Study of neuregulin-4 levels in newly diagnosed type 2 diabetes mellitus
Background: Neuregulin-4 is a recently recognized adipokine acting as ligands to tyrosine kinases receptor of the Erb B family. This adipose tissue augmented endocrine factor participates in the modulation of lipid and glucose metabolism and energy homeostasis. This novel adipokine is associated wit...
Saved in:
| Main Authors: | D Akshay, Ajay Chauhan, Parul Goyal, V Pranesh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-11-01
|
| Series: | Journal of Family Medicine and Primary Care |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jfmpc.jfmpc_265_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Potential of Neuregulin 4 as a Novel Biomarker and Therapeutic Agent for Vascular Complications in Type 2 Diabetes Mellitus
by: Dan X, et al.
Published: (2024-11-01) -
Asprosin and Neuregulin 4 in Obesity in Children
by: Ramazan Dulkadir, et al.
Published: (2025-04-01) -
Plasma Level’s of Neuregulin-1 in Healthy People
by: K. A. Zhbanov, et al.
Published: (2022-01-01) -
Circulating Asprosin and Neuregulin-4 in metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
by: Roshan Kumar Mahat, et al.
Published: (2025-05-01) -
Serum levels of sclerostin in prediabetes and its correlation with bone mineral density
by: Ajay Chauhan, et al.
Published: (2023-11-01)